
Novella
Culturing next-generation plant-based ingredients for enhanced nutrition and functionality.
About
Novella cultivates plant-derived ingredients using precision cell culturing, creating potent, full-spectrum bioactives without the whole plant. Their Novella ∞ product line is designed to supercharge foods and dietary supplements, boosting existing formulations to achieve greater wellness impact. They serve companies looking to enhance their products with natural, high-performance ingredients.
Key facts
At-a-glance profile data
- Website
- novella.co.il
- Headquarters
- Tel Aviv, Israel
- Founded
- 2021
- Employees
- 10
- Total funding
- $21M (Funding Round)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 14 May 2026 | Funding Round | $21M | - |
Add first review
Frequently asked
How much funding has Novella raised?
Novella has raised a total of $21M in funding. The most recent round on record is Funding Round.
How many employees does Novella have?
Novella has approximately 10 people on record.
What is Novella's current status?
Novella's current operating status is: Inactive.
